Acceptability of generic versus innovator oral medicines: not only a matter of taste.

Drug Discovery Today
Catherine TuleuFabrice Ruiz

Abstract

Optimum use of generic products would require equivalence, not only in terms of quality, safety, and efficacy in clinical studies, but also patient acceptability to not jeopardize treatment success because of non-adherence which would de facto limit the potential cost saving anticipated by their use. Although acceptability is a requirement for the authorization of pediatric innovator products, a survey of European Union (EU) regulatory authorities showed that few have a formal process for assessing patient acceptability of generic products during the registration processes. The current International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) focus on unifying guidance for the development and scrutiny of generics but should include acceptability alongside the other factors being considered for harmonization.

References

Aug 10, 1991·Lancet·H LévesqueH Courtois
Jun 1, 1989·Scandinavian Journal of Primary Health Care·D Bagger-Sjöbäck, G Bondesson
Jan 1, 1986·European Journal of Clinical Pharmacology·M UhariJ Jokisalo
Nov 1, 1987·Scandinavian Journal of Primary Health Care·T Jahnsen, P Thorn
Jan 1, 1996·The Pediatric Infectious Disease Journal·K M SamulakL G Rubin
Dec 21, 1996·BMJ : British Medical Journal·A J de CraenJ Kleijnen
Feb 27, 1999·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·M K Ito, S N Stolley
Jun 28, 2006·Pediatric Emergency Care·Michael K KimHalim M Hennes
Feb 15, 2007·Allergy·A RogkakouG Passalacqua
Mar 4, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Ritsuko MatsuoYasufumi Sawada
Apr 2, 2009·Chemical & Pharmaceutical Bulletin·Emi TokuyamaTakahiro Uchida
May 16, 2009·Psychology, Health & Medicine·Maria J FigueirasRob Horne
Aug 19, 2010·British Journal of Clinical Pharmacology·Martin G Duerden, Dyfrig A Hughes
Nov 26, 2010·International Journal of Pharmaceutics·Katharina WoertzJörg Breitkreutz
Nov 26, 2010·European Journal of Clinical Pharmacology·Else-Lydia ToverudInger Wabø
Mar 23, 2011·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·A WollnerR Cohen
Nov 18, 2011·Archives of Disease in Childhood·Dave BaguleySaul N Faust
Nov 24, 2011·Health Economics·Helen Dakin, Sarah Wordsworth
Apr 3, 2012·Chemical & Pharmaceutical Bulletin·Yutaka InoueIkuo Kanamoto
Nov 23, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pierre TattevinRémy Gauzit
Apr 22, 2014·International Journal of Pharmaceutics·Peter UestuenerSebastiano A G Lava
Jul 2, 2015·The Journal of Clinical Psychiatry·Chittaranjan Andrade
Jul 3, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yong Il KimKyoo Won Lee
Apr 26, 2016·The Journal of Pharmacy and Pharmacology·Fabrice RuizAmeziane Aoussat
Oct 27, 2017·The Journal of Pharmacy and Pharmacology·Thibault ValletAmeziane Aoussat
Nov 11, 2017·BMC Health Services Research·Béatrice RinerPhilippe Carrère
May 26, 2018·JAMA : the Journal of the American Medical Association·Craig M HalesCynthia L Ogden
May 14, 2019·Postgraduate Medicine·Richard DolinarElaine Nguyen
Jun 16, 2019·Archives of Disease in Childhood·Sofia NordenmalmBenjamin Pelle
Apr 15, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jennifer WalshSmita Salunke
Aug 14, 2020·Pharmaceutics·Thibault ValletVincent Boudy

❮ Previous
Next ❯

Citations

Nov 21, 2021·Archives of Disease in Childhood·Varsha PokharkarSmita Salunke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Wiener klinische Wochenschrift
Doris TschabitscherMarcus Müllner
Revista de saúde pública
Fabiola Sulpino Vieira, Paola Zucchi
Pharmacology & Therapeutics
R L Nation, L N Sansom
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Pierre TattevinRémy Gauzit
© 2021 Meta ULC. All rights reserved